BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity

Molecules. 2021 Nov 25;26(23):7139. doi: 10.3390/molecules26237139.

Abstract

Previously, we reported the in vitro growth inhibitory effect of diarylpentanoid BP-M345 on human cancer cells. Nevertheless, at that time, the cellular mechanism through which BP-M345 exerts its growth inhibitory effect remained to be explored. In the present work, we report its mechanism of action on cancer cells. The compound exhibits a potent tumor growth inhibitory activity with high selectivity index. Mechanistically, it induces perturbation of the spindles through microtubule instability. As a consequence, treated cells exhibit irreversible defects in chromosome congression during mitosis, which induce a prolonged spindle assembly checkpoint-dependent mitotic arrest, followed by massive apoptosis, as revealed by live cell imaging. Collectively, the results indicate that the diarylpentanoid BP-M345 exerts its antiproliferative activity by inhibiting mitosis through microtubule perturbation and causing cancer cell death, thereby highlighting its potential as antitumor agent.

Keywords: BP-M345; antitumor; apoptosis; diarylpentanoids; mitosis.

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Biological Products / chemistry*
  • Biological Products / pharmacology
  • Cell Proliferation / drug effects
  • Chromosome Segregation
  • HCT116 Cells
  • Humans
  • M Phase Cell Cycle Checkpoints / drug effects
  • Microtubules / chemistry
  • Microtubules / drug effects
  • Mitosis / drug effects*
  • Mitosis / genetics
  • Neoplasms / drug therapy*
  • Neoplasms / genetics

Substances

  • Antineoplastic Agents
  • Biological Products